ORINFOrion Corporation OY

About Orion Corporation OY (ORINF)

Orion Corporation OY (ORINF) is a Drug Manufacturers - General company headquartered in Espoo, Finland whose shares trade over-the-counter on the Pink tier.

Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. Pharmaceutical R&D focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. Orion's net sales in 2012 amounted to EUR 980 million and the company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.

ORINF key facts

Ticker symbol

ORINF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - General

Headquarters

Espoo, Finland

Country of incorporation

FI

Employees

3,514

Estimated market cap

$2.20B (as of Apr 16, 2025)

Shares outstanding

45,247,650

Reporting standard

International Reporting: Nasdaq OMX Nordic Exchange Helsinki

Audit status

Audited

Fiscal year end

12/31

Orion Corporation OY leadership

• Jari Karlson — CFO
• Heidi Ahti — Head of IR
• Susanna Siira — IR Manager

Explore more: Drug Manufacturers - General stocks · Healthcare sector · Pink stocks · OTC stocks starting with O